BridgeBio Pharma is seeking a Skeletal Dysplasia Account Manager for a remote position covering multiple territories in the United States. This role focuses on the launch of Infigratinib, a therapy for achondroplasia, requiring strong clinical knowledge and relationship-building skills with healthcare providers.
The ideal candidate will have 8–10 years in pharmaceuticals, proven success in product launches, and the ability to develop dynamic business plans. BridgeBio offers a competitive rewards package including generous health benefits and equity options.
#J-18808-Ljbffr